European Portfolio  |   North American Portfolio  |   Become a Member
Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD   US46333X1081

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector news 
Most relevant news about IRONWOOD PHARMACEUTICALS,
01/05 IRONWOOD PHARMACEUTICALS : to Present at J.P. Morgan Healthcare Conference
2014 IRONWOOD PHARMACEUTICALS : Technical Report on Biotech Stocks -- MannKind, Amgen..
2014 IRONWOOD PHARMACEUTICALS : Initiates Phase IIa Clinical Study of IW-9179 in Diab..
2014 IRONWOOD PHARMACEUTICALS : Earns $15 Million Milestone from Astellas upon Initia..
2014 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 2014 Healthcare Conferenc..
2014 IRONWOOD PHARMACEUTICALS : beats 3Q profit forecasts
2014 IRONWOOD PHARMACEUTICALS : Initiates Phase III Trial of 72 mcg Linaclotide in Ad..
2014 IRONWOOD PHARMACEUTICALS : Provides Third Quarter 2014 Investor Update
2014IRONWOOD PHARMACEUTICALS, INC. : quaterly earnings release
2014 IRONWOOD PHARMACEUTICALS : Biotech Equities Movers and Shakers - Organovo Holdin..
2014 IRONWOOD PHARMACEUTICALS : Presents IW-9179 Phase IIa Data at American College o..
2014 IRONWOOD PHARMACEUTICALS : Announces Initiation of Phase II Trial of Linaclotide..
2014 IRONWOOD PHARMACEUTICALS : to Host Third Quarter 2014 Investor Update Call
2014 IRONWOOD PHARMACEUTICALS : to Present at Morgan Stanley Global Healthcare Confer..
2014 IRONWOOD PHARMACEUTICALS : Appoints Two New Senior Executives to Support Continu..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
01/14 IRONWOOD PHARMACEUTICALS : to Present at J.P. Morgan Healthcare Conference
01/08 IRONWOOD PHARMACEUTICALS : to Participate at J.P. Morgan Healthcare Conference
01/05 IRONWOOD PHARMACEUTICALS : to Present at J.P. Morgan Healthcare Conference
2014 IRONWOOD PHARMACEUTICALS : Technical Report on Biotech Stocks -- MannKind, Amgen..
2014 IRONWOOD PHARMACEUTICALS : Initiates Phase IIa Clinical Study of IW-9179 in Diab..
2014 IRONWOOD PHARMACEUTICALS : Earns $15 Million Milestone from Astellas upon Initia..
2014 IRONWOOD PHARMACEUTICALS : Catabasis Names Angelika Fretzen, Ph.D., Vice Preside..
2014 IRONWOOD PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Missouri (Nov. 1..
2014 IRONWOOD PHARMACEUTICALS : Assigned Patent
2014 IRONWOOD PHARMACEUTICALS : to Present at Credit Suisse 2014 Healthcare Conferenc..
More news
Sector news Biotechnology & Medical Research - NEC
08:01a INCYTE : to Report Fourth Quarter/Year-End 2014 Financial Results on February 12
01/23 INCYTE : Earns $25 Million Milestone as Jakavi® (ruxolitinib) Recommended for Ap..
01/23 MEDIVATION : Astellas -enzalutamide phase 2 terrain trial demonstrated statistic..
01/22 QUINTILES TRANSNATIONAL : Investigator Initiated Trials is Topic of New Handbook..
01/22 PUMA BIOTECHNOLOGY : Announces Underwriters’ Full Exercise of Option to Pu..
01/22 MEDIVATION : Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Signi..
Plus d'actualités du secteur Biotechnology & Medical Research - NEC
Advertisement
Chart
Duration : Period :
Ironwood Pharmaceuticals, Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Partners :
Copyright © 2015 Surperformance. All rights reserved.